NCT06876792

Brief Summary

Accurate prediction of readiness to liberate patients from mechanical ventilation remains challenging. Conventional indices such as the rapid shallow breathing index (RSBI) and maximal inspiratory pressure (MIP) often miss early signs of injurious breathing patterns or regional ventilation asynchrony that can lead to extubation failure. Electrical impedance tomography (EIT) provides continuous, non-invasive imaging of regional lung ventilation. We developed a novel EIT-derived Flow Index (FI) which integrates the magnitude of inspiratory effort with the temporal synchrony of lung filling. This prospective, multicenter observational study aimed to (1) validate the predictive value of FI during spontaneous breathing trials (SBT) compared with conventional weaning indices, and (2) compare the predictive ability of EFI with traditional weaning indices(RSBI,MIP,P0.1).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2024

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 10, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 14, 2025

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

April 23, 2026

Status Verified

December 1, 2025

Enrollment Period

1.1 years

First QC Date

March 10, 2025

Last Update Submit

April 20, 2026

Conditions

Keywords

acute respiratory failureRespiratory driveElectrical Impedance Tomography (EIT)

Outcome Measures

Primary Outcomes (1)

  • Spontaneous Breathing Trial (SBT) Success Rate

    Proportion of patients who complete the 30-minute Spontaneous Breathing Trial (SBT) without signs of respiratory distress, hypoxemia, or hemodynamic instability.

    Within 30 minutes of Spontaneous Breathing Trial (SBT)

Secondary Outcomes (6)

  • Reintubation Rate within 48 hours

    Within 48 hours after extubation.

  • Ventilator-Free Days by Day 7

    Within 7 days after extubation.

  • ICU Mortality

    during the ICU stay or within 24 hours following transfer out of the ICU

  • Reintubation rate within 48 hours after extubation

    within the 48 hours after extubation

  • Ventilator-Free Days at Day 7 (VFD-7)

    Within 7 days after extubation

  • +1 more secondary outcomes

Study Arms (1)

Conventional method Respiratory Drive group

Conventional method Respiratory Drive group(Methods include: esophageal pressure monitoring, airway obstruction pressure (P0.1) )

Device: electrical impedance tomography

Interventions

Respiratory drive assessed by flow index measured by electrical impedance tomography.

Conventional method Respiratory Drive group

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

1. 150 critically ill patients requiring respiratory support were planned for inclusion 2. Age ≥18 years 3. Gender is not limited 4. Patients with expected duration of respiratory support \>24 hours

You may qualify if:

  • Age ≥18 years
  • Acute respiratory failure requiring intubation and mechanical ventilation ≥48 hours
  • Hemodynamic stability (no escalation of vasoactive agents)
  • Oxygenation: FiO₂ ≤0.5, PEEP ≤8 cmH₂O
  • Meeting standard ICU criteria for SBT readiness

You may not qualify if:

  • Neuromuscular diseases impairing spontaneous breathing
  • High cervical spinal cord injury
  • Deep sedation (RASS ≤-3)
  • Inadequate EIT signal quality
  • Contraindications to EIT
  • Pregnancy
  • Expected survival \<24 h

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Peking Union Medical College Hospital

Beijing, Beijing Municipality, China

Location

Fujian Provincial Hospital

Fuzhou, Fujian, 200025, China

Location

Department of Critical Care Medicine,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China.

Shanghai, 200025, China

Location

Study Officials

  • Hongping Qu

    Department of Critical Care Medicine,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine

    STUDY CHAIR
  • Jialin Liu

    Department of Critical Care Medicine,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine

    STUDY DIRECTOR
  • rui zhang

    Department of Critical Care Medicine,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 10, 2025

First Posted

March 14, 2025

Study Start

December 1, 2024

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

April 23, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation

Locations